Download PDF
Semin Respir Crit Care Med 2012; 33(03): 319-324
DOI: 10.1055/s-0032-1315644
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Long-Term Mortality after Pneumonia

Eric M. Mortensen
1   North Texas Veterans Health Care System, Dallas, Texas.
2   Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas.
3   Department of Clinical Sciences, University of Texas Southwestern Medical Center, Dallas, Texas.
,
Mark L. Metersky
4   Division of Pulmonary and Critical Care Medicine, University of Connecticut School of Medicine, Farmington, Connecticut.
› Author Affiliations
Further Information

Publication History

Publication Date:
20 June 2012 (online)

    Permissions and Reprints

Abstract

Although pneumonia is currently considered the eighth leading cause of death in the United States this estimate includes only short-term mortality. Evidence suggests that pneumonia may have significant longer-term effects and that hospitalization for pneumonia is associated with higher long-term mortality than for many other major medical conditions. Reasons for this increased mortality appear to be due to several factors, including cardiovascular disease, neoplasms, and alterations in immune function. Clinicians need to be aware that even for those patients who survive the initial episode of pneumonia there will still be an impact upon their potential survival for the coming years.

Keywords

community-acquired pneumonia - mortality - prognosis - long-term effects - pneumonia - long-term mortality
 

  • References

  • 1 Osler W. The Principles and Practice of Medicine. New York: D Appleton and Company; 1898: 109-112
    Google Scholar
  • 2 Kung HC, Hoyert DL, Xu JQ , et al. Deaths: Final Data for 2005. Hyattsville, MD: National Center for Health Statistics; 2008
    Google Scholar
  • 3 Mortensen EM, Coley CM, Singer DE , et al. Causes of death for patients with community-acquired pneumonia: results from the Pneumonia Patient Outcomes Research Team cohort study. Arch Intern Med 2002; 162 (9) 1059-1064
    CrossrefPubMedGoogle Scholar
  • 4 Kaplan V, Angus DC, Griffin MF, Clermont G, Scott Watson R, Linde-Zwirble WT. Hospitalized community-acquired pneumonia in the elderly: age- and sex-related patterns of care and outcome in the United States. Am J Respir Crit Care Med 2002; 165 (6) 766-772
    CrossrefPubMedGoogle Scholar
  • 5 Brancati FL, Chow JW, Wagener MM, Vacarello SJ, Yu VL. Is pneumonia really the old man's friend? Two-year prognosis after community-acquired pneumonia. Lancet 1993; 342 (8862) 30-33
    CrossrefPubMedGoogle Scholar
  • 6 Mortensen EM, Kapoor WN, Chang CC, Fine MJ. Assessment of mortality after long-term follow-up of patients with community-acquired pneumonia. Clin Infect Dis 2003; 37 (12) 1617-1624
    CrossrefPubMedGoogle Scholar
  • 7 Yende S, Angus DC, Ali IS , et al. Influence of comorbid conditions on long-term mortality after pneumonia in older people. J Am Geriatr Soc 2007; 55 (4) 518-525
    CrossrefPubMedGoogle Scholar
  • 8 Guertler C, Wirz B, Christ-Crain M, Zimmerli W, Mueller B, Schuetz P. Inflammatory responses predict long-term mortality risk in community-acquired pneumonia. Eur Respir J 2011; 37 (6) 1439-1446
    CrossrefPubMedGoogle Scholar
  • 9 Fine MJ, Auble TE, Yealy DM , et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997; 336 (4) 243-250
    CrossrefPubMedGoogle Scholar
  • 10 Schuetz P, Christ-Crain M, Thomann R , et al; ProHOSP Study Group. Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial. JAMA 2009; 302 (10) 1059-1066
    CrossrefPubMedGoogle Scholar
  • 11 Sligl WI, Eurich DT, Marrie TJ, Majumdar SR. Only severely limited, premorbid functional status is associated with short- and long-term mortality in patients with pneumonia who are critically ill: a prospective observational study. Chest 2011; 139 (1) 88-94
    CrossrefPubMedGoogle Scholar
  • 12 Waterer GW, Kessler LA, Wunderink RG. Medium-term survival after hospitalization with community-acquired pneumonia. Am J Respir Crit Care Med 2004; 169 (8) 910-914
    CrossrefPubMedGoogle Scholar
  • 13 Johnstone J, Eurich DT, Majumdar SR, Jin Y, Marrie TJ. Long-term morbidity and mortality after hospitalization with community-acquired pneumonia: a population-based cohort study. Medicine (Baltimore) 2008; 87 (6) 329-334
    CrossrefPubMedGoogle Scholar
  • 14 Bordon J, Wiemken T, Peyrani P , et al; CAPO Study Group. Decrease in long-term survival for hospitalized patients with community-acquired pneumonia. Chest 2010; 138 (2) 279-283
    CrossrefPubMedGoogle Scholar
  • 15 Bruns AH, Oosterheert JJ, Cucciolillo MC , et al. Cause-specific long-term mortality rates in patients recovered from community-acquired pneumonia compared with the general Dutch population. Clin Microbiol Infect 2011; 17 (5) 763-768
    CrossrefPubMedGoogle Scholar
  • 16 Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992; 45 (6) 613-619
    CrossrefPubMedGoogle Scholar
  • 17 Corrales-Medina VF, Madjid M, Musher DM. Role of acute infection in triggering acute coronary syndromes. Lancet Infect Dis 2010; 10 (2) 83-92
    CrossrefPubMedGoogle Scholar
  • 18 Yende S, D'Angelo G, Kellum JA , et al; GenIMS Investigators. Inflammatory markers at hospital discharge predict subsequent mortality after pneumonia and sepsis. Am J Respir Crit Care Med 2008; 177 (11) 1242-1247
    CrossrefPubMedGoogle Scholar
  • 19 Corrales-Medina VF, Suh KN, Rose G , et al. Cardiac complications in patients with community-acquired pneumonia: a systematic review and meta-analysis of observational studies. PLoS Med 2011; 8 (6) e1001048
    CrossrefPubMedGoogle Scholar
  • 20 Emsley HC, Hopkins SJ. Acute ischaemic stroke and infection: recent and emerging concepts. Lancet Neurol 2008; 7 (4) 341-353
    CrossrefPubMedGoogle Scholar
  • 21 Smeeth L, Cook C, Thomas S, Hall AJ, Hubbard R, Vallance P. Risk of deep vein thrombosis and pulmonary embolism after acute infection in a community setting. Lancet 2006; 367 (9516) 1075-1079
    CrossrefPubMedGoogle Scholar
  • 22 Mortensen EM, Copeland LA, Pugh MJ , et al. Diagnosis of pulmonary malignancy after hospitalization for pneumonia. Am J Med 2010; 123 (1) 66-71
    CrossrefPubMedGoogle Scholar
  • 23 Ortqvist A, Hedlund J, Wretlind B, Carlström A, Kalin M. Diagnostic and prognostic value of interleukin-6 and C-reactive protein in community-acquired pneumonia. Scand J Infect Dis 1995; 27 (5) 457-462
    CrossrefPubMedGoogle Scholar
  • 24 Glynn P, Coakley R, Kilgallen I, Murphy N, O'Neill S. Circulating interleukin 6 and interleukin 10 in community acquired pneumonia. Thorax 1999; 54 (1) 51-55
    CrossrefPubMedGoogle Scholar
  • 25 Bauer TT, Montón C, Torres A , et al. Comparison of systemic cytokine levels in patients with acute respiratory distress syndrome, severe pneumonia, and controls. Thorax 2000; 55 (1) 46-52
    CrossrefPubMedGoogle Scholar
  • 26 Kaplan V, Clermont G, Griffin MF , et al. Pneumonia: still the old man's friend?. Arch Intern Med 2003; 163 (3) 317-323
    CrossrefPubMedGoogle Scholar
  • 27 Myles PR, Hubbard RB, Gibson JE, Pogson Z, Smith CJ, McKeever TM. Pneumonia mortality in a UK general practice population cohort. Eur J Public Health 2009; 19 (5) 521-526
    CrossrefPubMedGoogle Scholar
  • 28 Cecere LM, Rubenfeld GD, Park DR, Root RK, Goss CH. Long-term survival after hospitalization for community-acquired and healthcare-associated pneumonia. Respiration 2010; 79 (2) 128-136
    CrossrefPubMedGoogle Scholar